Exploring the Role of GLP-1 Receptor Agonists in Ocular Disorders: An In-Depth Analysis of Existing Studies and Future Directions

• by Yu Luo, Yanting Xia, Xiaohong Gong, Meiling Hao, Qiping Wei, Liang Liao

• January 8, 2026

A systematic review of AI for predicting glaucoma progression: challenges and recommendations towards clinical implementation

• by Yichuan G. Liang, Leo Fan, Armando Teixeira-Pinto, Gerald Liew, Andrew J. R. White

• January 22, 2026

Biologics Tied to Lower Eye Risk in Psoriasis

Real-world data suggest lower rates of ocular surface disease with biologics vs nonbiologic systemic therapy.

• by Andrea Surnit

• April 20, 2026

• 2 min

Comparative Analysis of Medical and Surgical Interventions on Intraocular Pressure Variability in Glaucoma Patients at the University of Ilorin Teaching Hospital

• by Tokunbo Sarah Obajolowo, Ibrahim Abiodun Yusuf, Ambali Olamilekan Ambali, Biola Toibat Tota-Bolarinwa, Azeezat Bola Aderounmu, Fatai Olasunkanmi Olatunji

• January 22, 2026